Reflections on HBV Adaptation and Immune Interactions: Insights and Future Directions [0.03%]
HBV适应与免疫互作的思考——现状与未来方向
Ziyi He,Chenxi Wang,Huichuan Tian
Ziyi He
Reply to "The incidence of hepatitis flare and hepatic decompensation after nucleos(t)ide analogue cessation in chronic hepatitis B patients." [0.03%]
对“慢性乙肝患者停用核苷(酸)类似物后肝炎发作和肝脏失代偿的发病率”的回信
Edo J Dongelmans,Harry L A Janssen
Edo J Dongelmans
Madhusudana Girija Sanal,Jacob George
Madhusudana Girija Sanal
Missing the forest for the trees: time to address stool microbial load and everything else that realistically matters in microbiome studies [0.03%]
顾此失彼：是时候解决菌群研究中真正重要的问题了
Tharun Tom Oommen,Rizwan Ahamed,Cyriac Abby Philips
Tharun Tom Oommen
Reply to: "Could the paediatric acute hepatitis of unknown origin be related to a new autoimmune disease?" [0.03%]
关于“儿童原因不明急性肝炎是否与一种新的自身免疫性疾病相关？”的来信回复
Tatsuya Okamoto,Etsuro Hatano
Tatsuya Okamoto
Reply to: Comment on "Frailty and risk of metabolic dysfunction-associated steatotic liver disease and other chronic liver diseases" [0.03%]
关于“衰弱对代谢异常脂肪性肝病和其他慢性肝病风险的影响”的评论的回复
Qi Zhong,Hao-Wen Chen,Rui Zhou et al.
Qi Zhong et al.
Inclusion of Patients with Active Urinary Sediment in Treatment of Hepatorenal Syndrome [0.03%]
肝肾综合征治疗中纳入尿沉渣活跃的患者
Abdurrahman Hamadah,Kamel Gharaibeh
Abdurrahman Hamadah